8,550 Shares in HealthEquity, Inc. $HQY Bought by Fortis Capital Advisors LLC

Key Points

• Fortis Capital Advisors LLC acquired 8,550 shares of HealthEquity, Inc. valued at approximately $756,000 during the 1st quarter.
• Several hedge funds have increased their stakes in HealthEquity, with Invesco Ltd. raising its stake by 50.6% and Price T Rowe Associates increasing it by a staggering 995.6% in the same quarter.
• HealthEquity's stock received upgrades from multiple analysts, with Deutsche Bank raising the price target from $98.00 to $115.00 and maintaining a "buy" rating.

Fortis Capital Advisors LLC acquired a new position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 8,550 shares of the company's stock, valued at approximately $756,000.

Several other hedge funds have also added to or reduced their stakes in HQY. Invesco Ltd. raised its stake in HealthEquity by 50.6% during the 1st quarter. Invesco Ltd. now owns 2,446,198 shares of the company's stock worth $216,171,000 after buying an additional 821,425 shares during the period. Nuveen LLC acquired a new stake in shares of HealthEquity in the 1st quarter valued at about $53,076,000. Price T Rowe Associates Inc. MD raised its stake in shares of HealthEquity by 995.6% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 639,345 shares of the company's stock valued at $56,500,000 after purchasing an additional 580,988 shares during the period. Westfield Capital Management Co. LP acquired a new stake in shares of HealthEquity in the 1st quarter valued at about $49,787,000. Finally, Ameriprise Financial Inc. raised its stake in shares of HealthEquity by 148.1% in the 1st quarter. Ameriprise Financial Inc. now owns 669,939 shares of the company's stock valued at $59,203,000 after purchasing an additional 399,897 shares during the period. Institutional investors and hedge funds own 99.55% of the company's stock.

Insider Buying and Selling

In related news, EVP Michael Henry Fiore sold 1,794 shares of HealthEquity stock in a transaction dated Monday, July 7th. The stock was sold at an average price of $101.73, for a total transaction of $182,503.62. Following the completion of the transaction, the executive vice president owned 53,225 shares in the company, valued at approximately $5,414,579.25. This trade represents a 3.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 1.50% of the company's stock.

HealthEquity Trading Down 1.6%

HealthEquity stock opened at $91.51 on Thursday. HealthEquity, Inc. has a 52 week low of $74.07 and a 52 week high of $116.65. The company has a debt-to-equity ratio of 0.47, a quick ratio of 4.23 and a current ratio of 4.23. The stock has a market capitalization of $7.88 billion, a P/E ratio of 55.46, a PEG ratio of 1.33 and a beta of 0.50. The stock has a 50-day simple moving average of $93.74 and a 200 day simple moving average of $94.72.

Analyst Upgrades and Downgrades

Several analysts have issued reports on HQY shares. Deutsche Bank Aktiengesellschaft lifted their price target on HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a research note on Thursday, June 5th. Jefferies Financial Group lifted their price target on HealthEquity from $130.00 to $134.00 and gave the company a "buy" rating in a research note on Wednesday, September 3rd. JPMorgan Chase & Co. lifted their price target on HealthEquity from $125.00 to $126.00 and gave the company an "overweight" rating in a research note on Wednesday, September 3rd. Barrington Research restated an "outperform" rating and issued a $125.00 price objective on shares of HealthEquity in a report on Friday, August 29th. Finally, The Goldman Sachs Group raised their price objective on HealthEquity from $94.00 to $104.00 and gave the company a "neutral" rating in a report on Wednesday, June 4th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, the company has an average rating of "Buy" and a consensus target price of $119.77.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.